A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...
In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...
A recent study published in JAMA Psychiatry revealed that Ozempic (semaglutide), a medication commonly used for type 2 ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol ...
As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...
Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...
A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback